Stockreport

U.K. Paid $20 Million for New Coronavirus Tests. They Didn’t Work. [The New York Times]

GlaxoSmithKline PLC  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF LONDON — The two Chinese companies were offering a risky proposition: two million home test kits said to detect antibodies for the coronavirus for at least $20 million, [Read more]